TABLE III. Human papillomavirus (HPV) genotyping of biopsy samples (n = 77).
| Genotype | No lesions (N = 17) | LSIL (N = 30) | HSIL (N = 30) | Total (N = 77) |
|---|---|---|---|---|
| HPV11 | 1 (6%) | - | - | 1 (1%) |
| HPV16 | 10 (58%) | 14 (47%) | 20 (66%) | 44 (57%) |
| HPV18 | 1 (6%) | 6 (20%) | 2 (7%) | 9 (12%) |
| HPV31 | - | 2 (7%) | 2 (7%) | 4 (5%) |
| HPV33 | 1 (6%) | - | - | 1 (1%) |
| HPV53 | 1 (6%) | 1 (3%) | - | 2 (3%) |
| HPV58 | 2 (12%) | 4 (13%) | 4 (13%) | 10 (13%) |
| HPV70 | 1 (6%) | - | - | 1 (1%) |
| Multiple infections | - | 3 (10%) | 2 (7%) | 5 (7%) |
HSIL: high-grade squamous intraepithelial lesions; LSIL: low-grade squamous intraepithelial lesions.